https://www.selleckchem.com/pr....oducts/BIX-02189.htm
le, to minimize the risk of seizures. Rosuvastatin is a lipid-lowering drug that works by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme responsible for producing cholesterol in humans. The pharmacokinetic data of rosuvastatin are considerably variable across studies. To review the pharmacokinetics of rosuvastatin from randomised controlled trials (RCTs) in healthy adults. A review of the pharmacokinetics of rosuvastatin was performed using systematic search strategies. The Sheiner method was used